• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

281
63
47
46
28

COUNTRY

26
12
11
10
10

PRICE

308
492
969
1,278

PUBLISHED

59
100
305
1,278

PRODUCT TYPE

1,109
85
51
17
16

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE

Twinrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Twinrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation...

January 2014
FROM

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Canada Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Canada Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute...

January 2014
FROM

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute...

January 2014
FROM
Sexually-Transmitted Diseases in Germany 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in Germany 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in Germany 2014: Market Outlook and Emerging Opportunities

This new 280-page report presents detailed analysis of the German STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap...

January 2014
FROM
Sexually-Transmitted Diseases in the UK 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in the UK 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in the UK 2014: Market Outlook and Emerging Opportunities

This new 280-page report presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,...

January 2014
FROM
Sexually-Transmitted Diseases in Japan 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in Japan 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in Japan 2014: Market Outlook and Emerging Opportunities

This new 280-page report presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap...

January 2014
FROM
Sexually-Transmitted Diseases in Spain 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in Spain 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in Spain 2014: Market Outlook and Emerging Opportunities

This new 280-page report presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap...

January 2014
FROM
Sexually-Transmitted Diseases in Italy 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in Italy 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in Italy 2014: Market Outlook and Emerging Opportunities

This new 280-pages report presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap...

January 2014
FROM
Sexually-Transmitted Diseases in the US 2014: Market Outlook and Emerging Opportunities Sexually-Transmitted Diseases in the US 2014: Market Outlook and Emerging Opportunities - Product Thumbnail Image

Sexually-Transmitted Diseases in the US 2014: Market Outlook and Emerging Opportunities

This new 280-page report presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,...

January 2014
FROM
World Enteric Disease Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers World Enteric Disease Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers - Product Thumbnail Image

World Enteric Disease Market 2014: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Suppliers

This new 389-page report from the author contains 97 tables and provides analysis of the global enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts...

January 2014
FROM
Consensus Outlook: Multiple Sclerosis Consensus Outlook: Multiple Sclerosis - Product Thumbnail Image

Consensus Outlook: Multiple Sclerosis

Over the next five years, the global multiple sclerosis (MS) market is set to grow from $14 3 billion in 2012 to $21 5 billion in 2017 Primary drivers of this growth will be the entry of new pipeline...

December 2013
FROM

Enterococcus Faecium Infections - Pipeline Review, H2 2013

Enterococcus Faecium Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Enterococcus Faecium Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

December 2013
FROM

Burkholderia Infections - Pipeline Review, H2 2013

Burkholderia Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Burkholderia Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

December 2013
FROM

Shigella Infections (Shigellosis) - Pipeline Review, H2 2013

Shigella Infections (Shigellosis) - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Shigella Infections (Shigellosis) - Pipeline Review, H2 2013', provides an overview of the indication’s...

December 2013
FROM

Community-Acquired Infections - Pipeline Review, H2 2013

Community-Acquired Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Community-Acquired Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

December 2013
FROM

Bacteremia - Pipeline Review, H2 2013

Bacteremia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Bacteremia - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

December 2013
FROM

Rubella - Pipeline Review, H2 2013

Rubella - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Rubella - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

December 2013
FROM

Plague - Pipeline Review, H2 2013

Plague - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Plague - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

December 2013
FROM

Warts - Pipeline Review, H2 2013

Warts - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Warts - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

December 2013
FROM

Haemophilus Influenzae Infections - Pipeline Review, H2 2013

Haemophilus Influenzae Infections - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Haemophilus Influenzae Infections - Pipeline Review, H2 2013', provides an overview of the indication’s...

December 2013
FROM
Loading Indicator

Our Clients

Our clients' logos